Paul Sekhri, eGenesis CEO

George Church spin­off swal­lows a key man­u­fac­tur­ing part­ner as it preps CRISPR-edit­ed pig or­gans for an­i­mal test­ing

Re­search­ing, cloning and breed­ing gene-edit­ed pigs are core to eGe­n­e­sis’ au­da­cious mis­sion to grow or­gans that can be xeno­trans­plant­ed in­to hu­mans. But per­haps un­sur­pris­ing­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.